News

Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET… Learn more
POSTED: 4/11/2022
AACR Annual Meeting 2022
April 8-13, 2022 DCP/PREVENT-funded Project Presentations Session OPO.IM01.01 - Tumor Immunobiology 5631 - Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous polyposis Presenter/Authors Chakrapani Tripathi, Roderick H. Dashwood. Texas A&M… Learn more
POSTED: 4/1/2022
Screen capture of the cover of CP-CTNet March 2022 Newsletter.

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet).
POSTED: 3/31/2022
A group of women from diverse backgrounds.
Philadelphia, March 25, 2022 — The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), is more than halfway to its recruiting goal of 128,905 participants with more than 20% of participants in the United States being… Learn more
POSTED: 3/25/2022
An image of foods high in calcium, vitamin D, and vitamin D receptors.
This issue of Nutrition Frontiers showcases gut permeability with calcium and/or vitamin D3, microRNAs role in suppressing colitis and inflammation-associated colon cancer, and how dietary spinach reshapes gut microbiome.… Learn more
POSTED: 3/18/2022
An illustration displaying signal amplification.
Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat… Learn more
POSTED: 2/9/2022
AUTHOR: Jack J. Lee, Ph.D.
Illustration showing progression from normal liver to nonalcoholic steatohepatitis.
While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C… Learn more
POSTED: 2/4/2022
Partial screen grab of the ULACNet Zoom meeting showing a grid 9 participants.
This issue recognizes January as Cervical Cancer Awareness Month by presenting four articles entitled, "ULACNet Annual Meeting: A Global Network Together in One (Zoom) Room", "Perseverance Through the COVID… Learn more
POSTED: 1/28/2022
Photo of a health insurance statement.
Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study.
POSTED: 1/26/2022
The Division of Cancer Prevention (DCP) of the National Cancer Institute (NCI) hosted a virtual workshop to obtain information relevant to the potential creation of a new NCI-funded cancer screening clinical trials network… Learn more
POSTED: 1/25/2022

A meeting of statistical leads from the seven NCI Community Oncology Research Program (NCORP) Research Bases with statisticians from the Division of Cancer Prevention (DCP) Biometry Research Group took place on July… Learn more
POSTED: 1/20/2022
An illustration of a displaying a bronchoscopy, entering via nasal swabs to detect a suspicious nodule.
Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited.

In the United States, almost 60… Learn more
POSTED: 1/14/2022
AUTHOR: Jack J. Lee, Ph.D.
Partial screen grab of the December 2021 issue of the CP-CTNet Newsletter.

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet).
POSTED: 12/22/2021
Thank You--50th Anniversary of the National Cancer Act
Fifty years ago this week, the National Cancer Act was signed into law, kick-starting research that has changed how cancer is prevented, detected, diagnosed, treated, and survived, and moving us closer to a time when no one… Learn more
POSTED: 12/20/2021
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
An older woman with a handful of oral medications.
For older adults undergoing treatment for advanced cancer, results from a clinical trial show that a health measurement tool called a geriatric assessment can be an important part of treatment planning. In the trial, older… Learn more
POSTED: 12/15/2021
Drawings of COVID-19 cells.
This issue we highlight diet quality on COVID risk and severity, along with kava’s role in lung cancer in active smokers, as well as lifelong exposure of bioactives such as ECGC and sulforaphane from green tea and broccoli… Learn more
POSTED: 12/1/2021
An illustration displaying possible inherited risk carriers within a family.
If your family member had cancer, would you want to know if you carried a gene mutation that increased your risk of the same cancer? This question is at the heart of three novel research projects underway to determine how… Learn more
POSTED: 11/29/2021
The NCI Community Oncology Research Program (NCORP) annual meeting for grantees in August 2021 virtually brought together representatives from every NCORP Research Base and Community and Minority Underserved Site to discuss… Learn more
POSTED: 11/10/2021
Screen capture of the Fall 2021 issue the CP-CTNet Newsletter.
The first day of autumn was September 22nd. Fall reminds us that change can be a beautiful process. It’s the season that conjures up memories of heading back to school, visits to the pumpkin patch, jumping in piles of… Learn more
POSTED: 10/12/2021
Estimated cases of myelodysplastic syndrome cases in the US each year.
In a clinical study underway, scientists hope to unravel the complexities of a group of poorly understood and relatively rare blood disorders that often lead to cancer. In myelodysplastic syndromes (MDS), the problem arises… Learn more
POSTED: 10/5/2021
AUTHOR: Susan Jenks
none
In this issue, we feature: ULACNet-101 Getting Ready for Recruitment, ROCCHHA Opens Enrollment in Puerto Rico and Brazil for ULACNet-201, and an interview with Dr. Lenka Kolevic. Translations are available in Spanish and… Learn more
POSTED: 9/20/2021
NCI graphic showing checked off text boxes
A year ago, I said that coming on board as the Division of Cancer Prevention Director in July 2020 was a “challenge,” adding that I had faith in science that the pandemic would be solved soon. Science has brought us a… Learn more
POSTED: 9/20/2021
AUTHOR: Philip E. Castle, Ph.D., M.P.H.
40% of women who inherit a mutation in their BRCA1 gene will develop ovarian cancer in their lifetime.
Researchers in gynecologic oncology have begun testing a promising surgery for premenopausal women at high genetic risk for ovarian cancer that avoids early menopause and may prevent these malignancies from developing.… Learn more
POSTED: 9/7/2021
AUTHOR: Susan Jenks
Leaders in NCI's Division of Cancer Prevention: Dr. Philip Castle, Director and Dr. Lori Minasian, Deputy Director.
This Healthcast podcast commemorates the National Cancer Act's 50th anniversary by highlighting the progress the National Cancer Institute has made in cancer prevention. Leaders in NCI's Division of Cancer… Learn more
POSTED: 8/31/2021
Healthy foods displayed on a table, including salmon, garlic, avocado, and walnuts.
This issue we showcase genetically predicted circulating PUFAs and colorectal cancer risk, miRNAs as early indicators of lifestyle changes in women with breast cancer, and how antibiotics, historically used in preclinical… Learn more
POSTED: 8/19/2021